Loading...
S66 logo

Star Combo Pharma LimitedASX:S66 Stock Report

Market Cap AU$26.3m
Share Price
AU$0.20
AU$1.97
90.1% undervalued intrinsic discount
1Y18.2%
7D-4.9%
1D
Portfolio Value
View

Star Combo Pharma Limited

ASX:S66 Stock Report

Market Cap: AU$26.3m

Star Combo Pharma (S66) Stock Overview

Manufactures and distributes health food products and nutritional supplements in Australia and China. More details

S66 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends2/6

S66 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Star Combo Pharma Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Star Combo Pharma
Historical stock prices
Current Share PriceAU$0.20
52 Week HighAU$0.28
52 Week LowAU$0.13
Beta0.36
1 Month Change-13.33%
3 Month Change-4.88%
1 Year Change18.18%
3 Year Change69.57%
5 Year Change-23.53%
Change since IPO-75.32%

Recent News & Updates

Analysis Article Feb 11

Benign Growth For Star Combo Pharma Limited (ASX:S66) Underpins Stock's 26% Plummet

Star Combo Pharma Limited ( ASX:S66 ) shareholders won't be pleased to see that the share price has had a very rough...
Analysis Article Dec 24

Insufficient Growth At Star Combo Pharma Limited (ASX:S66) Hampers Share Price

Star Combo Pharma Limited's ( ASX:S66 ) price-to-earnings (or "P/E") ratio of 8.5x might make it look like a strong buy...
Analysis Article Nov 26

Is Now The Time To Put Star Combo Pharma (ASX:S66) On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Sep 08

Star Combo Pharma Limited's (ASX:S66) Share Price Boosted 31% But Its Business Prospects Need A Lift Too

Despite an already strong run, Star Combo Pharma Limited ( ASX:S66 ) shares have been powering on, with a gain of 31...

Recent updates

Analysis Article Feb 11

Benign Growth For Star Combo Pharma Limited (ASX:S66) Underpins Stock's 26% Plummet

Star Combo Pharma Limited ( ASX:S66 ) shareholders won't be pleased to see that the share price has had a very rough...
Analysis Article Dec 24

Insufficient Growth At Star Combo Pharma Limited (ASX:S66) Hampers Share Price

Star Combo Pharma Limited's ( ASX:S66 ) price-to-earnings (or "P/E") ratio of 8.5x might make it look like a strong buy...
Analysis Article Nov 26

Is Now The Time To Put Star Combo Pharma (ASX:S66) On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Sep 08

Star Combo Pharma Limited's (ASX:S66) Share Price Boosted 31% But Its Business Prospects Need A Lift Too

Despite an already strong run, Star Combo Pharma Limited ( ASX:S66 ) shares have been powering on, with a gain of 31...
Analysis Article Aug 27

Here's Why We Think Star Combo Pharma (ASX:S66) Might Deserve Your Attention Today

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Jul 17

Star Combo Pharma Limited (ASX:S66) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Star Combo Pharma Limited ( ASX:S66 ) shares have continued their recent momentum with a 26% gain in the last month...
Analysis Article Jun 16

The Return Trends At Star Combo Pharma (ASX:S66) Look Promising

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article May 09

Optimistic Investors Push Star Combo Pharma Limited (ASX:S66) Shares Up 26% But Growth Is Lacking

Star Combo Pharma Limited ( ASX:S66 ) shareholders are no doubt pleased to see that the share price has bounced 26% in...
Analysis Article May 07

Should You Be Adding Star Combo Pharma (ASX:S66) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article Mar 15

Star Combo Pharma Limited's (ASX:S66) 27% Price Boost Is Out Of Tune With Earnings

Star Combo Pharma Limited ( ASX:S66 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article Mar 01

Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
Analysis Article Jan 05

There's Reason For Concern Over Star Combo Pharma Limited's (ASX:S66) Massive 30% Price Jump

Star Combo Pharma Limited ( ASX:S66 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article Nov 11

Some Star Combo Pharma Limited (ASX:S66) Shareholders Look For Exit As Shares Take 31% Pounding

Star Combo Pharma Limited ( ASX:S66 ) shares have had a horrible month, losing 31% after a relatively good period...
Analysis Article Aug 23

Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up

Star Combo Pharma Limited ( ASX:S66 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article Aug 13

Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Analysis Article Jun 12

Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Star Combo Pharma Limited ( ASX:S66 ) shareholders that were waiting for something to happen have been dealt a blow...
Analysis Article May 12

Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
Analysis Article Mar 20

Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

There wouldn't be many who think Star Combo Pharma Limited's ( ASX:S66 ) price-to-sales (or "P/S") ratio of 0.6x is...
Analysis Article Nov 21

Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Key Insights Star Combo Pharma's Annual General Meeting to take place on 28th of November CEO Su Zhang's total...
Analysis Article Mar 02

Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Shareholders didn't seem to be thrilled with Star Combo Pharma Limited's ( ASX:S66 ) recent earnings report, despite...
Analysis Article Dec 24

Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Shareholder Returns

S66AU Personal ProductsAU Market
7D-4.9%-6.2%0.08%
1Y18.2%-33.4%3.1%

Return vs Industry: S66 exceeded the Australian Personal Products industry which returned -34.7% over the past year.

Return vs Market: S66 exceeded the Australian Market which returned 2.9% over the past year.

Price Volatility

Is S66's price volatile compared to industry and market?
S66 volatility
S66 Average Weekly Movement12.2%
Personal Products Industry Average Movement12.2%
Market Average Movement10.5%
10% most volatile stocks in AU Market17.5%
10% least volatile stocks in AU Market4.3%

Stable Share Price: S66 has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: S66's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004n/aSu Zhangwww.starcombo.com.au

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products.

Star Combo Pharma Limited Fundamentals Summary

How do Star Combo Pharma's earnings and revenue compare to its market cap?
S66 fundamental statistics
Market capAU$26.34m
Earnings (TTM)AU$4.12m
Revenue (TTM)AU$23.99m
6.4x
P/E Ratio
1.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
S66 income statement (TTM)
RevenueAU$23.99m
Cost of RevenueAU$18.02m
Gross ProfitAU$5.98m
Other ExpensesAU$1.86m
EarningsAU$4.12m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.03
Gross Margin24.91%
Net Profit Margin17.16%
Debt/Equity Ratio0.1%

How did S66 perform over the long term?

See historical performance and comparison

Dividends

1.9%
Current Dividend Yield
12%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/22 06:40
End of Day Share Price 2026/05/22 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Star Combo Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.